Vertex Pharmaceuticals Total Non-Operating Income/Expense 2010-2024 | VRTX
Vertex Pharmaceuticals total non-operating income/expense for the twelve months ending June 30, 2024 was $0.563B, a 65.38% increase year-over-year.
- Vertex Pharmaceuticals annual total non-operating income/expense for 2023 was $0.548B, a 830.4% decline from 2022.
- Vertex Pharmaceuticals annual total non-operating income/expense for 2022 was $-0.075B, a 45.07% increase from 2021.
- Vertex Pharmaceuticals annual total non-operating income/expense for 2021 was $-0.052B, a 119.84% decline from 2020.